CB1 Capital Management predicts Cannabis could disrupt the healthcare industry in a big way. The firm's Founding Partner and Chief Investment Officer Todd Harrison explains why he thinks medical marijuana will migrate from state dispensaries, to become medicine prescribed by doctors through insurance in the next decade.
Harrison says the only way the U.S. government would get their hands on the money in this market opportunity is through the FDA. "That's where we think it goes, follow the money," says Harrison.
"This is not so much a trade about commerce, as it is a trade about healthcare," said Harrison. "We think that this is going to migrate towards medicine." One of CB1 Capital Management's holdings GW Pharmaceuticals is up 30 percent over the past three months. Harrison expects this company to publish research showing the efficacy of cannabis treatment this summer.
Everyone may be talking about the death of movie theaters, but here are the sleeper hit movies you may have missed in '25, and five not to miss in '26.
California Pizza Kitchen enters a new era as fresh investment fuels growth, innovation, and global expansion—showing how legacy restaurant brands stay relevant.
Holiday shopping heats up as Tom’s Guide editor Kate Kozuch reveals the tech gifts everyone wants, from wellness gadgets to gaming buzz—and how to score deals!
